drugset / Trial / NCT00578474

A Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy Tubes

NCT00578474

Phase 3 Completed 911 enrolled Alcon Research
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if an otic formulation is safe and effective in treating middle ear infections in patients with ear tubes.

Timeline

Start
2005-12
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Moxidex Unknown Other
Comparator Ofloxacin Small molecule Other

Indications